New Horizon Health

OverviewSuggest Edit

New Horizon Health is a company that develops digestive tract cancer screening technology and products. The company designs digestive tract cancer test kits for home use and operates testing laboratories. It also aims to establish big data and artificial intelligence capabilities to aid its development of cancer screening technology.
TypePrivate
Founded2013
Websitenewhorizonbio.com

New Horizon Health Financials and Metrics

Summary Metrics

Founding Date

2013

New Horizon Health total Funding

$106.5 m

New Horizon Health latest funding size

$20 m

Time since last funding

a year ago

New Horizon Health investors

New Horizon Health's latest funding round in April 2020 was reported to be $20 m. In total, New Horizon Health has raised $106.5 m
Show all financial metrics

New Horizon Health Online and Social Media Presence

Embed Graph

New Horizon Health News and Updates

First Cancer Early Screening Company Listed on HKEX as New Horizon Health Debuts

SHANGHAI, Feb. 17, 2021 /PRNewswire/ -- Qiming's portfolio company New Horizon Health (SEHK:6606) officially listed on the Main Board of Hong Kong Stock Exchange (HKEx) today. This is the first listed Chinese cancer early screening company. The issue price is HK$26.66 per share; the stock...

Chinese Cancer Screening Firm New Horizon Health Raises $20M In Series D Round

China’s early-stage cancer screening biotech company New Horizon Health announced today that it has raised US$20 million in a Series D financing round, led by private equity fund Omniscience. American Exome Asset Management and existing investors Qiming Venture Partners, SBCVC also participated in…

New Horizon Health Frequently Asked Questions

  • When was New Horizon Health founded?

    New Horizon Health was founded in 2013.

  • Who are New Horizon Health competitors?

    Competitors of New Horizon Health include xCures, Yizhun Intelligent and Genomill Health.